Stealth BioTherapeutics Corp (NASDAQ:MITO) FDA Orphan Drug Designation: Investors Are Delighted

May 13, 2022

One of the stocks to have made a big move on Thursday was that of Stealth BioTherapeutics Corp (NASDAQ:MITO), which ended the day with gains of as much as 31% amidst heavy interest. It is likely that the stock is going to be on focus today as well. Trading Data On Thursday, MITO stock soared 31.51% to $0.25 with more than 77.02 million shares traded, compared to volume of 692K…